Antiangiogenic gene therapy of myeloproliferative disease developed in transgenic mice expressing P230 bcr/abl
Miyake, K, Inokuchi, K, Miyake, N, Dan, K, Shimada, TVolume:
12
Language:
english
Journal:
Gene Therapy
DOI:
10.1038/sj.gt.3302427
Date:
March, 2005
File:
PDF, 199 KB
english, 2005